IDO1 expression can be either triggered as a counter regulatory response to cytokines like IL-1β and IL-6 released from tumor-infiltrating immune cells or maintained through tumor-intrinsic oncogenic signaling [71, 72]. Here, IL6 is linked to neoplasm.